Automatic blood grouping analyzer is an analyzer that can forward and reverse ABO blood group, Rh (D) blood group test, irregular antibody screening and cross-matching of blood test. It mainly consists of liquid handling system, incubator, centrifuge, interpretoscope, and microcomputer system.

Quest Diagnostics said it has acquired Blueprint Genetics in an all-cash equity transaction. Helsinki, Finland-based Blueprint Genetics has deep expertise in gene variant interpretation based on next-generation sequencing (NGS) and proprieta

Researchers at the Laboratory of Bionanophotonic Systems (BIOS) at EPFL's School of Engineering have developed an optical biosensor that slashes the sepsis diagnosis time from several days to just a few minutes. Their approach draws on recen

FDA has issued an emergency use authorization (EUA) for the Centers for Disease Control and Prevention’s Coronavirus detection test. Up until now, the Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel has only been used at CDC lab

Cardinal Health nixed its relationship with Suqian, China-based Siyang Holymed after learning that the FDA-authorized supplier had shifted production of Cardinal's surgical gowns to non-approved sites without the proper controlled environmen

Jabil Inc. is consolidating its healthcare businesses under Jabil Healthcare. These include Jabil’s embedded-sensors business, its injection molding business through Nypro, and its orthopedics, spine, trauma, and medical instruments operat

Researchers from Linköping University are behind a new study that has used artificial intelligence to investigate whether it is possible to discover biological networks using deep learning, in which entities known as "artificial neural netw

Abbott Laboratories has won CE mark for the new Gallant implantable cardioverter-defibrillator (ICD) and CRT-D devices. The Abbott Park, Il-based company received approval in Europe on the heels of ICD Week, a celebration of 40 years of the

Ares Genetics, a Curetis Group company, will collaborate with BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe.

China has been a large and ever-expanding market for Roche, driving much of the company's international growth, and this week, the firm said several initiatives and developments in that country keep it a crucial strategic market for its diag

Abcam said on Thursday that it has acquired the gene editing platform and oncology product portfolio of Applied StemCell for the research and diagnostic markets.